Leveraging Generative AI to Accelerate Biocuration of Medical Actions for Rare Disease
Authors:
- Enock NiyonkuruENEnock Niyonkuru
- J Harry CaufieldJCJ Harry Caufield
- Leigh CarmodyLCLeigh Carmody
- Sabrina ToroSTSabrina Toro
- Trish WhetzelTWTrish Whetzel
- Hannah BlauHBHannah Blau
- Mauricio SotoMSMauricio Soto
- Elena CasiraghiElena Casiraghi
- Leonardo ChimirriLCLeonardo Chimirri
- Justin T ReeseJRJustin T Reese
- Giorgio ValentiniGVGiorgio Valentini
Preprint
Abstract
Background: Structured representations of clinical data can support computational analysis of individuals and cohorts, and ontologies representing disease entities and phenotypic abnormalities are now commonly used for translational research. The Medical Action Ontology (MAxO) provides a computational representation of treatments and other actions taken for the clinical management of patients. Currently, manual biocuration is used to assign MAxO terms to rare diseases, enabling clinical management of rare diseases to be described computationally for use in clinical decision support and mechanism discovery. However, it is challenging to scale manual curation to comprehensively capture information about medical actions for the more than 10,000 rare diseases. Methods: We present AutoMAxO, a semi-automated workflow that leverages Large Language Models (LLMs) to streamline MAxO biocuration for rare diseases. AutoMAxO first uses LLMs to retrieve candidate curations from abstracts of relevant publications. Next, the candidate curations are matched to ontology terms from MAxO, Human Phenotype Ontology (HPO), and MONDO disease ontology via a combination of LLMs and post-processing techniques. Finally, the matched terms are presented in a structured form to a human curator for approval. Results: We used this approach to process 4,918 unique medical abstracts and identified annotations for 21 rare genetic diseases, we extracted 18,631 candidate disease-treatment curations, 538 of which were confirmed and transferred to the MAxO annotation dataset. Conclusion: The results of this project underscore the potential of generative AI to accelerate precision medicine by enabling a robust and comprehensive curation of the primary literature to represent information about diseases and procedures in a structured fashion. Although we focused on MAxO in this project, similar approaches could be taken for other biomedical curation tasks.Keywords
This publication has 12 references indexed in Scilit:
- PubTator 3.0: an AI-powered literature resource for unlocking biomedical knowledgeNucleic Acids Research, 2024
- Structured Prompt Interrogation and Recursive Extraction of Semantics (SPIRES): a method for populating knowledge bases using zero-shot learningBioinformatics, 2024
- A medical multimodal large language model for future pandemicsnpj Digital Medicine, 2023
- The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human diseaseMed, 2023
- Large language models encode clinical knowledgeNature, 2023
- Database resources of the national center for biotechnology informationNucleic Acids Research, 2021
- OBO Foundry in 2021: operationalizing open data principles to evaluate ontologiesDatabase: The Journal of Biological Databases and Curation, 2021
- How many rare diseases are there?Nature Reviews Drug Discovery, 2019
- BioBERT: a pre-trained biomedical language representation model for biomedical text miningBioinformatics, 2019
- Pressing needs of biomedical text mining in biocuration and beyond: opportunities and challengesDatabase: The Journal of Biological Databases and Curation, 2016